Biotricity Inc. (BTCY)
Stock Price:
$1.18 USD
-0.02 (-1.67%)
Updated Aug 10, 2020 4:00 PM EDT - End of day
Key Info
| Market Cap |
39.39M |
| Revenue (ttm) |
1.42M |
| Net Income (ttm) |
-11.07M |
| Shares Out |
33.38M |
| EPS (ttm) |
-0.32 |
| PE Ratio |
n/a |
| Forward PE |
n/a |
| Dividend |
n/a |
| Dividend Yield |
n/a |
Stock Quote
| Trading Day |
Aug 10, 2020 |
| Last Price |
$1.18 |
| Previous Close |
$1.20 |
| Change ($) |
-0.02 |
| Change (%) |
-1.67% |
| Day's Open |
1.20 |
| Day's Range |
1.12 - 1.23 |
| Day's Volume |
48,993 |
| 52-Week Range |
0.26 - 2.21 |
More Stats
| Market Cap |
39.39M |
| Enterprise Value |
40.78M |
| Earnings Date (est) |
n/a |
| Ex-Dividend Date |
n/a |
| Shares Outstanding |
33.38M |
| Float |
24.97M |
| EPS (basic) |
-0.315 |
| EPS (diluted) |
-0.32 |
| FCF / Share |
-0.22 |
| Dividend |
n/a |
| Dividend Yield |
n/a |
| Earnings Yield |
n/a |
| FCF Yield |
n/a |
| Payout Ratio |
n/a |
| Shares Short |
n/a |
| Short Ratio |
n/a |
| Short % of Float |
n/a |
| Beta |
2.32 |
| PE Ratio |
n/a |
| Forward PE |
n/a |
| P/FCF Ratio |
n/a |
| PS Ratio |
27.79 |
| PB Ratio |
n/a |
| Revenue |
1.42M |
| Operating Income |
-11.02M |
| Net Income |
-11.07M |
| Free Cash Flow |
-7.86M |
| Net Cash |
-1.39M |
| Net Cash / Share |
-0.04 |
| Gross Margin |
48.84% |
| Operating Margin |
-777.52% |
| Profit Margin |
-798.80% |
| FCF Margin |
-554.61% |
| ROA |
-467.43% |
| ROE |
n/a |
| ROIC |
n/a |
Stats based on trailing-twelve-month (ttm) numbers.
Analyst Summary
Analyst Ratings (0)
| Buy |
0 |
| Overweight |
0 |
| Hold |
0 |
| Underweight |
0 |
| Sell |
0 |
*No analysts have provided price targets for this stock.
Financial Performance
Financial numbers in millions USD.
Financial Overview
| Year | 2019 | 2018 | 2017 | 2016 | 2016 | 2015 | 2014 |
|---|
| Revenue | 1.42 | 0.40 | - | - | - | - | - |
| Revenue Growth | 256.03% | - | - | - | - | - | - |
| Gross Profit | 0.69 | 0.06 | - | - | - | - | - |
| Operating Income | -11.02 | -8.59 | -8.60 | -7.12 | -4.97 | -5.13 | -1.71 |
| Net Income | -11.07 | -8.59 | -8.62 | -7.81 | -7.28 | -5.19 | -1.71 |
| Shares Outstanding | 35.96 | 33.38 | 30.17 | 25.87 | 25.81 | 21.85 | 14.41 |
| Earnings Per Share | -0.32 | -0.26 | -0.29 | -0.30 | -0.29 | -0.24 | -0.12 |
| Operating Cash Flow | -7.86 | -5.22 | -4.87 | -3.75 | -2.38 | -1.96 | -1.38 |
| Free Cash Flow | -7.86 | -5.22 | -4.87 | -3.75 | -2.38 | -1.96 | -1.38 |
| Cash & Equivalents | 0.95 | 0.06 | 0.84 | 0.42 | 0.02 | 0.41 | 0.45 |
| Total Debt | 2.34 | 0.87 | - | 1.56 | 1.31 | 0.78 | - |
| Net Cash / Debt | -1.39 | -0.80 | 0.84 | -1.13 | -1.29 | -0.37 | 0.45 |
| Assets | 2.00 | 0.49 | 0.93 | 0.47 | 0.07 | 0.52 | 0.52 |
| Liabilities | 5.00 | 2.27 | 0.76 | 4.86 | 4.14 | 1.76 | 0.18 |
| Book Value | -3.00 | -1.78 | 0.17 | -4.38 | -4.07 | -1.24 | 0.34 |
Numbers in millions USD, except per-share numbers.
Company Details
| Full Name |
Biotricity Inc. |
| Country |
United States |
| Employees |
24 |
| CEO |
Waqaas Al-Siddiq |
Stock Information
| Ticker Symbol |
BTCY |
| Stock Exchange |
US OTC |
| Sector |
Healthcare |
| Industry |
Medical Devices |
| Unique Identifier |
OTCMKTS: BTCY |
Description
Biotricity, Inc., medical technology company, provides biometric data monitoring solutions in the United States. The company focuses on delivery of remote monitoring solutions to medical, healthcare, and consumer markets, including diagnostic and post-diagnostic solutions for lifestyle and chronic illnesses. It offers Bioflux mobile cardiac telemetry technology, an integrated electrocardiogram (ECG) device and software solution. Biotricity, Inc. has a research partnership with the University of Calgary to determine the predictive value of ECG readings in preventative healthcare applications; and a strategic partnership with Verizon to develop EMS solutions for first responders by integrating its Bioflux solution. The company is based in Redwood City, California.